|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 80, 94-101, Copyright © 1980 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JB Hancock, PL Forshaw and MP Kaye
Because of the occasional need for a prosthesis in coronary artery
operations, we investigated the potential use of microporous
polytetrofluoroethylene (PTFE) with and without antiplatelet drugs as an
aorta-coronary bypass graft in 43 dogs. In 13 animals without antiplatelet
drugs, no grafts were patent at 1 month. When antiplatelet drugs were used
(25 dogs), the 1 month patency rate increased to 64%. The addition of
antibiotic treatment 1 month patency rate to 80%. The 6 month patency rate
in dogs treated with antiplatelet drugs, preoperative bowel preparation,
and systemic antibiotics was 60%. Our data indicate that microporous PTFE
grafts used as coronary artery bypass grafts in dogs can be maintained
patent for at least 6 months when the animals are treated with antiplatelet
drugs.
ARTICLES
Gore-Tex (polytetrafluoroethylene) in canine coronary artery bypass
This article has been cited by other articles:
![]() |
A. J. McLarty, M. R. Phillips, D. R. Holmes Jr, and H. V. Schaff Aortocoronary Bypass Grafting With Expanded Polytetrafluoroethylene: 12-Year Patency Ann. Thorac. Surg., May 1, 1998; 65(5): 1442 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Bidstrup Coronary Artery Bypass Graft Patency Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 282 - 287. [Abstract] [PDF] |
||||
![]() |
R. Fasol, P. Zilla, P. Preiss, U. von Oppell, J. Odell, and B. Reichart Allogenic, Multidonor In Vitro Endothelialization of Small Diameter PTFE Grafts in Baboons Vascular and Endovascular Surgery, January 1, 1991; 25(1): 64 - 71. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |